Sleeve gastrectomy most effectively enhances transplant eligibility and survival in morbidly obese ESRD patients, with dual GLP-1/GIP agonists as a viable alternative.
The post Weight Loss Strategies and Transplant in ESRD first appeared on Physician’s Weekly.
